Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.

[1]  Punnee Pitisuttithum,et al.  Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. , 2004, The Journal of infectious diseases.

[2]  H. Pehamberger,et al.  Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her‐2/neu , 2003, International journal of cancer.

[3]  P. Farmer.  AIDS as a global emergency. , 2003, Bulletin of the World Health Organization.

[4]  D. Birx,et al.  Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. , 2003, AIDS research and human retroviruses.

[5]  M. Waugh,et al.  Taxanes Synergize with the Bispecific Antibody MDXH447 to Enhance Antibody-Dependent Cell-Mediated Cytotoxicity , 2003, Journal of chemotherapy.

[6]  J. Clements,et al.  Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. , 2002, AIDS research and human retroviruses.

[7]  Mardge H. Cohen,et al.  Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women. , 2002, The Journal of infectious diseases.

[8]  G. Landucci,et al.  Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count. , 2001, AIDS research and human retroviruses.

[9]  D. Birx,et al.  A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans. , 2000, AIDS research and human retroviruses.

[10]  R. Haubrich,et al.  Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. , 1999, The Journal of infectious diseases.

[11]  R. Redfield,et al.  Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine. , 1999, AIDS research and human retroviruses.

[12]  C. Walker,et al.  Prime-boost immunization strategies against HIV. , 1998, AIDS research and human retroviruses.

[13]  R. Siliciano,et al.  Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. , 1998, The Journal of infectious diseases.

[14]  J. Tartaglia,et al.  Canarypox virus-based vaccines: prime-boost strategies to induce cell-mediated and humoral immunity against HIV. , 1998, AIDS research and human retroviruses.

[15]  G. Skowron,et al.  gp1207‐directed antibody‐dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV‐1 disease , 1997, AIDS.

[16]  A. Fauci,et al.  Host factors in the pathogenesis of HIV disease , 1997, Immunological reviews.

[17]  J. Sullivan,et al.  Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study. , 1997, The Journal of infectious diseases.

[18]  G. Landucci,et al.  Predominance of Detrimental Humoral Immune Responses to HIV‐1 in AIDS Patients with CD4 Lymphocyte Counts Less Than 400/mm3 , 1997, Scandinavian journal of immunology.

[19]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[20]  B. Wahrén,et al.  Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity. , 1996, AIDS research and human retroviruses.

[21]  J. Margolick,et al.  HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. , 1996, Journal of immunology.

[22]  S. J. Clark,et al.  HIV-specific cellular and humoral immune responses in primary HIV infection. , 1996, AIDS research and human retroviruses.

[23]  Ali Ahmad,et al.  Antibody‐dependent cellular cytotoxicity in HIV infections , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  D. Dormont,et al.  Relationships between humoral factors in HIV‐1‐infected mothers and the occurrence of HIV infection in their infants , 1995, Clinical and experimental immunology.

[25]  E. Charlebois,et al.  Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1. , 1994, The Journal of infectious diseases.

[26]  R. Morisset,et al.  Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. , 1994, Journal of acquired immune deficiency syndromes.

[27]  C. Fundarò,et al.  Antibody‐dependent cellular cytotoxicity and neutralizing activity in sera of HIV‐1‐infected mothers and their children , 1993, Clinical and experimental immunology.

[28]  S. Buchbinder,et al.  Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. , 1991, The Journal of infectious diseases.

[29]  J. Giorgi,et al.  Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. , 1990, Journal of immunology.

[30]  J. Habeshaw,et al.  Failure of ADCC to predict HIV‐associated disease progression or outcome in a haemophiliac cohort , 1990, Clinical and experimental immunology.

[31]  J. Bartlett,et al.  Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. , 1990, Journal of immunology.

[32]  C. Rinaldo,et al.  Antibody-dependent cellular cytotoxicity mediated by CD16+ lymphocytes from HIV-seropositive homosexual men. , 1990, Clinical immunology and immunopathology.

[33]  I Quinti,et al.  Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. , 1990, The Journal of infectious diseases.

[34]  D. Tyler,et al.  Minireview Anti-HIV-1 ADCC , 1989 .

[35]  R. Detels,et al.  Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression , 1989, Journal of Clinical Immunology.

[36]  D. Tyler,et al.  CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS , 1988, The Lancet.

[37]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[38]  A. Fauci,et al.  Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. , 1987, Journal of immunology.

[39]  P. Cresswell,et al.  Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. , 1985, Journal of immunology.

[40]  J. Zighelboim,et al.  Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. , 1975, Journal of immunology.

[41]  V. Facchinetti,et al.  Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. , 2003, Haematologica.

[42]  L. Morrison,et al.  Innate immunity to herpes simplex virus type 2. , 2003, Viral immunology.

[43]  R. Sekulovich,et al.  Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. , 2000, The Journal of infectious diseases.

[44]  J. Cox.  HIV-1-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC). , 1999, Methods in molecular medicine.

[45]  C. Nilsson,et al.  Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys. , 1994, Vaccine.

[46]  H. Lyerly,et al.  Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. , 1987, AIDS research and human retroviruses.